Xoma Corp Del Com (NASDAQ:XOMA)

CAPS Rating: 1 out of 5

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.

XOMA News and Commentary

Caps

How do you think XOMA will perform against the market?

Add Stock to CAPS Watchlist

All Players

328 Outperform
43 Underperform
 

All-Star Players

24 Outperform
19 Underperform
 

Wall Street

10 Outperform
1 Underperform
 

Top XOMA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFBiologyFool (61.71)
Submitted March 07, 2014

Knockdown after EOA data looks like a decent entry point.

jed71 (99.86)
Submitted February 01, 2017

I am down-thumbing this completely out of principle. This might run higher against me short term, but I have plenty of patience to wait for this to crater. I have no idea who in the investing community would think that this is a good investment, but… More

XOMA VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about XOMA.

Recs

0
Member Avatar RES7 (98.90) Submitted: 3/9/2017 12:05:43 AM : Underperform Start Price: $5.34 XOMA Score: -29.34

jed71

Recs

1
Member Avatar SmartAce (99.93) Submitted: 2/1/2017 3:26:47 PM : Underperform Start Price: $4.50 XOMA Score: -50.25

When tempted to fight fire with fire, remember that the Fire Department usually uses water.

Recs

3
Member Avatar jed71 (99.86) Submitted: 2/1/2017 11:51:27 AM : Underperform Start Price: $4.55 XOMA Score: -48.11

I am down-thumbing this completely out of principle. This might run higher against me short term, but I have plenty of patience to wait for this to crater. I have no idea who in the investing community would think that this is a good investment, but it’s incredibly embarrassing that this continues to be a NASDAQ traded stock. Stubs such as this one make me seriously question the NASDAQ’s rules for allowing a company to become publicly traded on its platform. This doesn’t even deserve OTC status, but I am happy to put it on my red thumb list given it meets my self-imposed “shortable” criteria. (This is NOT an endorsement to short this stock in real-life – do you own research and be very careful shorting volatile bio-tech stubs, such as this.)

I am not going to spend a bunch of time writing a detailed pitch on this because, as I said, this is about as obvious as a red thumb gets. I laughed when I saw the $1.2 BILLION in negative equity!!! Why in the world would anyone continue to throw money at this beast?!?!?!? That is an INCREDIBLE amount of capital that is **POOF*** gone!

They are burning about $14MM a quarter in cash, and of course, they have very limited revenues and only $24MM in remaining assets. Most of their remaining assets are cash, but it only gives them about 6 months of operating expenses before they’ll need to belly back up to the ATM.

The funniest part of this company to me is if you look at the max timeframe chart with share prices. I am seeing where this stock was almost $10,000 a share back in the late 80’s. Maybe they can pull a rabbit out of their hat but I’m going to go with my gut here, which tells me this is nothing more than a DESTROYER OF ALL THINGS CAPITAL. Don’t get sucked into the hype here - avoid this one like the plague.

Leaderboard

Find the members with the highest scoring picks in XOMA.

Score Leader

hateninja

hateninja (< 20) Score: +216.82

The Score Leader is the player with the highest score across all their picks in XOMA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
hateninja < 20 8/27/2010 Underperform 3Y $53.80 -86.88% +129.95% +216.82 1 Comment
blan49 < 20 9/2/2010 Underperform 3W $57.60 -87.74% +123.96% +211.70 0 Comment
jdbenham < 20 8/25/2006 Underperform NS $516.00 -98.63% +100.33% +198.96 0 Comment
tmhuston 65.09 3/13/2008 Underperform 1Y $732.00 -99.04% +95.79% +194.83 0 Comment
fiuser < 20 1/22/2008 Underperform 3M $810.00 -99.13% +94.02% +193.15 0 Comment
stockomatico < 20 10/2/2006 Underperform 1Y $570.00 -98.76% +93.57% +192.33 0 Comment
njwillie1 97.37 9/29/2006 Underperform 3M $546.00 -98.71% +93.34% +192.05 0 Comment
drakitin 99.58 8/15/2008 Underperform 1Y $702.00 -98.99% +92.73% +191.73 0 Comment
BrianRuth 99.39 3/5/2007 Underperform 1Y $918.00 -99.23% +87.38% +186.61 2 Comments
HunterNumber9 72.90 1/3/2011 Underperform 5Y $108.80 -93.51% +91.14% +184.65 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 84.41 6/25/2015 Underperform 3W $81.40 -91.33% +16.04% +107.37 0 Comment
TrackCreditSuiss 91.30 11/13/2012 Outperform NS $55.60 -87.30% +77.03% -164.33 0 Comment
TrackZacks < 20 7/6/2012 Underperform 3M $76.60 -19.58% +3.82% +23.40 8/23/2012 @ $61.60 1 Comment
TrackRothCapital 70.49 6/28/2012 Outperform NS $61.80 -88.58% +84.06% -172.63 0 Comment
TrackCowenandCo 87.56 5/14/2012 Outperform NS $54.20 -86.97% +81.29% -168.26 0 Comment
trackmlvcapital < 20 3/31/2011 Outperform NS $57.80 -87.79% +83.63% -171.41 0 Comment
TrackZacks < 20 1/6/2011 Outperform 3M $135.60 -65.78% +10.24% -76.03 3/20/2012 @ $46.40 1 Comment
TrackWedbush 84.28 1/4/2011 Outperform NS $127.20 -94.45% +92.89% -187.34 0 Comment
TrackPacificGrow < 20 7/29/2008 Outperform NS $582.00 -91.17% +11.32% -102.49 4/17/2012 @ $51.40 0 Comment
TrackSusquehanna 90.99 5/13/2008 Outperform NS $645.00 -98.91% +79.85% -178.76 0 Comment
TrackLadenburg < 20 5/12/2008 Outperform NS $642.00 -98.90% +79.94% -178.84 0 Comment
TrackPZK < 20 3/25/2008 Outperform NS $795.00 -93.53% +2.84% -96.37 4/17/2012 @ $51.40 0 Comment
TrackRBCCapMkts 87.88 3/5/2008 Outperform NS $782.97 -99.10% +90.20% -189.30 0 Comment
TrackCanaccord 67.67 11/27/2007 Outperform NS $924.00 -99.24% +79.98% -179.22 0 Comment
TrackJimCramer 84.41 10/3/2007 Outperform 3W $1,155.00 -92.95% +36.45% -129.40 6/25/2015 @ $81.40 0 Comment
TrackBWS 96.63 8/1/2007 Outperform NS $630.00 -78.60% -41.38% -37.21 4/9/2009 @ $134.85 0 Comment
TrackRodmanRen < 20 1/24/2007 Outperform NS $753.00 -99.06% +81.74% -180.81 0 Comment

Featured Broker Partners